Evidence map›Paper›PMID 35360055›Full record

ArticleFrontiers in endocrinology2022

The Impact of Hormonal Contraceptive Use on Serotonergic Neurotransmission and Antidepressant Treatment Response: Results From the NeuroPharm 1 Study.

Søren Vinther Larsen, Brice Ozenne, Kristin Köhler-Forsberg, Asbjørn Seenithamby Poulsen, Vibeke Høyrup Dam, Claus Svarer, Gitte Moos Knudsen, Martin Balslev Jørgensen, Vibe Gedso Frokjaer

Open access · goldAbstract readClinical Study
In one paragraph

Article in Frontiers in endocrinology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Søren Vinther LarsenNeurobiology Research Unit, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.
Brice OzenneNeurobiology Research Unit, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.
Kristin Köhler-ForsbergNeurobiology Research Unit, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.
Asbjørn Seenithamby PoulsenNeurobiology Research Unit, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.
Vibeke Høyrup DamNeurobiology Research Unit, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.
Claus SvarerNeurobiology Research Unit, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.
Gitte Moos KnudsenNeurobiology Research Unit, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.
Martin Balslev JørgensenPsychiatric Center Copenhagen, Mental Health Services in the Capital Region of Denmark, Copenhagen, Denmark.
Vibe Gedso FrokjaerNeurobiology Research Unit, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.
Copenhagen University Hospital · DKMental Health Services · DKUniversity of Copenhagen · DKCapital Region of Denmark · DKRigshospitalet · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Hormonal contraceptive (HC) use has been associated with an increased risk of developing a depressive episode. This might be related to HC's effect on the serotonergic brain system as suggested by recent cross-sectional data from our group, which show that healthy oral contraceptive (OC) users relative to non-users have lower cerebral serotonin 4 receptor (5-HT4R) levels. Here, we determine if cerebral 5-HT4R binding differs between HC non-users, OC users, and hormonal intrauterine device (HIUD) users among women with an untreated depressive episode. Also, we test if antidepressant drug treatment response and its association with pre-treatment 5-HT4R binding depends on HC status. Methods: [ Results: We found no evidence of a difference in global 5-HT4R binding between depressed HC users and non-users (p≥0.51). A significant crossover interaction (p=0.02) was observed between non-users and OC users in the association between baseline global 5-HT4R binding and week eight rΔHAMD Conclusions: We found no difference in 5-HT4R binding between HC users

Indexed as

Antidepressive AgentsBrainContraceptives, OralCross-Sectional StudiesFemaleHumansSynaptic TransmissionAntidepressive AgentsContraceptives, Oral[11C]SB207145hormonal contraceptionhormonal intrauterine devicemajor depressive disorderoral contraceptionserotoninserotonin 4 receptorsex steroid hormones

Identifiers

PMID35360055
PMCPMC8962375
OpenAlexW4220929408

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.